Clinical Trials Logo

Cardiovascular Disease clinical trials

View clinical trials related to Cardiovascular Disease.

Filter by:

NCT ID: NCT00756379 Active, not recruiting - Clinical trials for Coronary Artery Disease

Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease

Century
Start date: March 11, 2009
Phase: N/A
Study type: Interventional

The Century Trial is a single center Phase III randomized study sponsored by the Albert Weatherhead III Foundation and conducted by Dr. K. Lance Gould. The study hypothesis is that a combined image-treatment regimen of PET + comprehensive program of lifestyle modification and lipid lowering drugs to target lipid level will result in an improved cardiovascular risk score when compared to current standard optimal medical therapy, potentially resulting in a lower rate of death, non-fatal myocardial infarction (MI) and revascularization procedures during long term follow-up when compared with current standard of care. If our hypothesis is correct, we will not only improve our ability to prevent and treat CAD but we will also illustrate that, even with the expenses of behavioral interventions and imaging techniques, we can be very cost effective. This information may help patients at risk or with known CAD to obtain insurance coverage to prevent the disease as well as providing a more effective way of treating it.

NCT ID: NCT00743301 Recruiting - Metabolic Syndrome Clinical Trials

The Effect of Palm Olein, Olive Oil and Lard and on Risk Markers of Cardiovascular Disease

A305
Start date: August 2008
Phase: N/A
Study type: Interventional

The aim of this study is to compare the effects of a diet rich in palm olein, a fraction of palm oil, to a diet rich in olive oil and a diet rich in Danish lard on plasma total-, LDL and HDL cholesterol as well as triacylglycerol (TAG), fasting insulin and glucose, C reactive protein and plasminogen activator inhibitor 1 in healthy men. The investigators hypothesis is that palm olein and olive oil will have the same effect on plasma total cholesterol, LDL- and HDL concentration and maybe also on the secondary outcome parameters that are related to cardiovascular disease risk. This may be caused by the differences in the sn-positioning of palmitic acid in palm olein. This difference may cause the palmitic acid in palm olein to be more prone to soap formations and excretion than palmitic acid from other sources, e.g. lard. This study is a double blinded, randomized, controlled 3 x 3 week crossover intervention study, without washout periods. The participants receive the three test foods in random order, decided by draw of lots. Blood samples are drawn in duplicate (on two following days) before and after each dietary period.

NCT ID: NCT00741728 Recruiting - Clinical trials for Cardiovascular Disease

Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population

PPSIII
Start date: June 2008
Phase: N/A
Study type: Observational

The aim of the present PPS3 study is (1) to assess the determinants of the regulation of heart rate and blood pressure variations and carotid properties (under different physiologic stimulations) and (2) to evaluate the respective contribution of heart rate, blood pressure variations and carotid properties to cardiovascular morbidity and mortality including sudden death during 10 years at least in healthy considered subjects.

NCT ID: NCT00741585 Completed - Stroke Clinical Trials

Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment

HYGIA
Start date: September 1, 2008
Phase: Phase 4
Study type: Interventional

The HYGIA study was designed to investigate prospectively 1. the prognostic value of ambulatory blood pressure (BP) monitoring among subjects primarily evaluated at primary care settings 2. the impact of changes in ambulatory BP during follow-up in cardiovascular, cerebrovascular, metabolic, and renal risk in hypertensive patients 3. the influence of circadian time of treatment in cardiovascular, cerebrovascular, metabolic, and renal risk in hypertensive patients 4. the prevalence of an altered BP profile as a function of antihypertensive treatment, circadian time of treatment, age, and presence of diabetes, among other factors.

NCT ID: NCT00738179 Active, not recruiting - Clinical trials for Cardiovascular Disease

Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea to Prevent Cardiovascular Disease

SAVE
Start date: September 2008
Phase: Phase 3
Study type: Interventional

Obstructive Sleep Apnea (OSA) is a condition in which a person stops breathing for several seconds at a time due to relaxation of the throat muscles. This can occur many times during sleep. It is known to cause sleepiness and poor concentration during the day. Research indicates that OSA may be a modifiable risk factor for cardiovascular disease due to its association with hypertension, stroke, heart attack and sudden death. The standard therapy for symptomatic OSA is continuous positive airway pressure (CPAP). CPAP has been shown to effectively reduce snoring, obstructive episodes and daytime sleepiness and to modestly reduce blood pressure and other risk factors for cardiovascular disease. The overall aim of SAVE is to determine if CPAP can reduce the risk of heart attack, stroke or heart failure for people with OSA.

NCT ID: NCT00737945 Completed - Clinical trials for Cardiovascular Disease

Prognostic Value of Endothelial Dysfunction and Coronary Complexity

Start date: August 2006
Phase: N/A
Study type: Observational

The investigators test the additional clinical value of the physiological assessment of endothelial function to the morphological assessment of coronary complexity and classical risk score in predicting cardiovascular events.

NCT ID: NCT00736632 Completed - Hypertension Clinical Trials

Vitamin D, Insulin Resistance, and Cardiovascular Disease

Start date: May 2006
Phase: N/A
Study type: Interventional

In recent years, vitamin D has been shown not only to be important for bone and calcium metabolism but also for homeostasis of critical tissues involved in vascular disease in patients with diabetes. Epidemiological studies indicated the high prevalence of vitamin D deficiency among Type 2 DM patients and suggest an increased risk of cardiovascular disease and hypertension with low vitamin D levels. The objective of this proposal is to evaluate the effects of vitamin D replacement on blood pressure control and vascular disease in vitamin D deficient hypertensive patients with diabetes

NCT ID: NCT00736086 Completed - Clinical trials for Cardiovascular Disease

RISE: A Clinical Evaluation of the StarClose™ Vascular Closure System

Start date: March 2006
Phase: Phase 4
Study type: Observational

To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.

NCT ID: NCT00724399 Completed - Clinical trials for Cardiovascular Disease

Preventive Health Practices in Women

Start date: January 2006
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate women's level of knowledge and health practices regarding cardiovascular health and identify barriers to appropriate health practice.

NCT ID: NCT00720967 Not yet recruiting - Clinical trials for Cardiovascular Disease

Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery

SeRenaD-CPB
Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether preoperative hemodialysis or intraoperative modified ultrafiltration are effective for patients with non-dialysis dependent severe renal dysfunction undergoing open heart surgery.